Nov 20: Sanofi-Aventis under the spotlight

Andrew Jack, pharmaceuticals correspondent, analyses the View from the Top interview with Chris Viehbacher, chief executive of Sanofi-Aventis, the Eurozone's largest pharma company. He focuses on: the power of scientists, the dangers of acquisitions, and the beneifts of emerging markets and US healthcare reform. Presenter: Richard Milne, European business correspondent